AU Patent

AU2011252039B2 — Pharmaceutical compositions comprising hydromorphone and naloxone

Assigned to Euro Celtique SA · Expires 2014-06-12 · 12y expired

What this patent protects

The present invention relates to prolonged release pharmaceutical dosage forms, the manufacture thereof as well as their use for administration to human beings.

USPTO Abstract

The present invention relates to prolonged release pharmaceutical dosage forms, the manufacture thereof as well as their use for administration to human beings.

Drugs covered by this patent

Patent Metadata

Patent number
AU2011252039B2
Jurisdiction
AU
Classification
—
Expires
2014-06-12
Drug substance claim
No
Drug product claim
No
Assignee
Euro Celtique SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.